103.96
전일 마감가:
$107.04
열려 있는:
$103.73
하루 거래량:
723.06K
Relative Volume:
1.28
시가총액:
$6.00B
수익:
$1.33B
순이익/손실:
$120.04M
주가수익비율:
50.71
EPS:
2.05
순현금흐름:
$172.71M
1주 성능:
+0.67%
1개월 성능:
+0.90%
6개월 성능:
+8.40%
1년 성능:
+42.70%
Merit Medical Systems Inc Stock (MMSI) Company Profile
명칭
Merit Medical Systems Inc
전화
(801) 253-1600
주소
1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT
MMSI을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
MMSI
Merit Medical Systems Inc
|
103.96 | 6.00B | 1.33B | 120.04M | 172.71M | 2.05 |
![]()
ISRG
Intuitive Surgical Inc
|
494.61 | 177.21B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
221.59 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
89.61 | 44.32B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
213.35 | 31.33B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
BAX
Baxter International Inc
|
31.35 | 16.08B | 17.28B | 108.00M | 391.00M | 0.20 |
Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-03-28 | 개시 | JP Morgan | Overweight |
2024-12-11 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2024-06-28 | 개시 | Robert W. Baird | Outperform |
2024-04-11 | 개시 | CL King | Buy |
2024-02-07 | 개시 | BofA Securities | Neutral |
2023-12-21 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2022-12-20 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2021-01-05 | 업그레이드 | Needham | Hold → Buy |
2020-09-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
2020-02-25 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
2020-02-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2019-12-12 | 다운그레이드 | Wells Fargo | Market Perform → Underperform |
2019-09-24 | 개시 | Oppenheimer | Outperform |
2019-09-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2019-07-26 | 다운그레이드 | Needham | Buy → Hold |
2019-07-26 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
2018-10-02 | 재확인 | Needham | Buy |
2018-08-07 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
2018-07-24 | 재확인 | Needham | Buy |
2018-06-01 | 재확인 | Needham | Buy |
2018-05-18 | 재확인 | SunTrust | Buy |
2018-04-26 | 재확인 | Needham | Buy |
2018-04-20 | 개시 | Needham | Buy |
2018-03-01 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
2017-08-28 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2017-07-20 | 개시 | BofA/Merrill | Buy |
2017-06-20 | 개시 | SunTrust | Buy |
2017-04-05 | 개시 | Wells Fargo | Outperform |
모두보기
Merit Medical Systems Inc 주식(MMSI)의 최신 뉴스
Which GCs Sold Stock In March? Broadcom, Meta And More - Law360
Biopsy Devices Market Projected To Witness Massive Growth, - openPR.com
3 Reasons to Avoid MMSI and 1 Stock to Buy Instead - Yahoo Finance
Merit Medical Systems COO Neil Peterson sells shares for $522,650 By Investing.com - Investing.com South Africa
Merit Medical Systems COO Neil Peterson sells shares for $522,650 - Investing.com India
How Do Investors Really Feel About Merit Medical Systems? - Benzinga
Percutaneous Drainage Catheters Market Outlook 2024-2031: Top - openPR.com
(MMSI) Investment Report - news.stocktradersdaily.com
Brachytherapy Market Is Expected to Generate USD 1.6 Billion - openPR.com
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now - Nasdaq
Vanguard Group Inc. Buys 63,314 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) - MarketBeat
Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)? - simplywall.st
JPMorgan starts Merit Medical with Overweight, $120 target - Investing.com Australia
JPMorgan starts Merit Medical with Overweight, $120 target By Investing.com - Investing.com Canada
This Merit Medical Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Assessing Merit Medical Systems: Insights From 12 Financial Analysts - Benzinga
JPMorgan Initiates Merit Medical Systems at Overweight With $120 Price Target - MarketScreener
Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD - The Manila Times
Major Breakthrough: Merit Medical's GERD Solution Achieves 94% Success in New Guidelines - Stock Titan
Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results - Zacks Investment Research
Merit Medical releases 12-month efficacy results of WRAPSODY WAVE trial - TipRanks
Advancements In Peripheral Support Catheters Driving The Market: Key Trend Transforming the Transradial Acc... - WhaTech
Merit Medical Announces 12-Month Efficacy Results For WRAPSODY CIE In Hemodialysis Patients - Nasdaq
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) - The Manila Times
Merit Medical Systems Reports Promising Six-Month and Twelve-Month Results for WRAPSODY CIE in WAVE Trial - Nasdaq
Merit Medical's WRAPSODY Achieves 70% Success Rate vs 41% Standard Treatment - Stock Titan
Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch - Yahoo Finance
(MMSI) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Biopsy Devices Market Generated Opportunities, Future Scope - openPR
Prostatic Artery Embolization Market Is Booming Worldwide - openPR
Merit Medical Systems, Inc. Rings the Opening Bell - Nasdaq
Merit Medical Systems, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership - The Manila Times
U.S. Uterine Fibroid Treatment Market Future Business - openPR
Major Trend In The Procedure Trays Global Market 2025-2034: Innovative Solutions For Patient Safety Merit M... - WhaTech
Gastrointestinal Stent Market Booms with 6.0% CAGR Growth | TOP - openPR
Merit Medical: A Success Story That Keeps Getting Better - Seeking Alpha
MMSI Announces Commencement of Patient Enrollment in PREEMIE Study - Yahoo Finance
Interventional Neuroradiology Market Expansion: From $1.9B - openPR
Charles Schwab Investment Management Inc. Boosts Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) - Defense World
Operating Procedure Trays Market: Key Drivers and Market - openPR
Merit Medical enrols first subject in trial of Bloom Micro Occluder System - Yahoo Finance
First patient enrolled in Merit Medical occluder system study - Mass Device
First Patient Enrolled in Merit Medical's PREEMIE Study - The Manila Times
Merit Medical Begins Clinical Trial for Groundbreaking Premature Baby Heart Treatment - StockTitan
Merit Medical Systems, Inc. to Host Earnings Call - ACCESS Newswire
Insider Selling: Merit Medical Systems, Inc. (NASDAQ:MMSI) CEO Sells $3,252,895.20 in Stock - Defense World
Insider Selling: Merit Medical Systems, Inc. (NASDAQ:MMSI) Insider Sells $3,087,000.00 in Stock - Defense World
Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Purchased by Edgestream Partners L.P. - MarketBeat
Hedge Fund and Insider Trading News: Steven Cohen, Christer Gardell, Boaz Weinstein, Rokos Capital Management, Silver Point Capital, Starboard Value, Graham Capital Management, Triata Capital, Walker & Dunlop Inc (WD), Merit Medical Systems Inc (M - Insider Monkey
Insider Selling: FRED LAMPROPOULOS Unloads $3.56M Of Merit Medical Systems Stock - Benzinga
Merit Medical Systems Inc (MMSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):